HRP20150456T1 - Metoda pripreme argatroban monohidrata - Google Patents

Metoda pripreme argatroban monohidrata Download PDF

Info

Publication number
HRP20150456T1
HRP20150456T1 HRP20150456TT HRP20150456T HRP20150456T1 HR P20150456 T1 HRP20150456 T1 HR P20150456T1 HR P20150456T T HRP20150456T T HR P20150456TT HR P20150456 T HRP20150456 T HR P20150456T HR P20150456 T1 HRP20150456 T1 HR P20150456T1
Authority
HR
Croatia
Prior art keywords
angle
spade
relative intensity
argatroban
preparing
Prior art date
Application number
HRP20150456TT
Other languages
English (en)
Inventor
Jacopo Zanon
Giovanna Libralon
Andrea Nicole'
Original Assignee
Lundbeck Pharmaceuticals Italy S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck Pharmaceuticals Italy S.P.A. filed Critical Lundbeck Pharmaceuticals Italy S.P.A.
Publication of HRP20150456T1 publication Critical patent/HRP20150456T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Claims (11)

1. Metoda pripreme aratroban monohidrata koja sadrži najmanje jedan korak od: Koncentriranje reakcijske smjese koja sadrži sirovinski argatroban u ostatak koji se može miješati; Otapanje ostatka sa sirovinskim argatrobanom s organskim otapalom i izdvajanje pročišćenog argatrobana kristalizacijom tretiranjem organskog otapala sa kristalizirajućim otapalom izabranim između izopropanola i n-propanola; Izdvanjanje argatroban monohidrata rekristalizacijom pročišćenog argatrobana, izoliranog u prethodnom koraku, iz metanolno-vodene otopine dodatkom obezbojavajućeg ugljena, zagrijavanjem na refluks temperaturi, zatim filtracijom ugljena te hlađenje s refluks temperature na temperaturu između 15-25°C u vremenu između 11-17 sati.
2. Metoda pripreme argatroban monohidrata prema zahtjevu 1, pri čemu je kristalizirajuće otapalo izopropanol.
3. Metoda pripreme argatroban monohidrata prema zahtjevu 1 koja sadrži daljnji korak: Pripreme sirovinskog argatrobana iz (2R,4R)-1-[NG-nitro-N2-(3-metil-8-kinolinsulfonil)-1-arginil]-4-metil-2-piperidin karboksilne kiseline u metanolu/octenoj kiselini.
4. Metoda pripreme argatroban monohidrata prema zahtjevu 1, pri čemu je reakcijska smjesa tretirana s vodenim bazičnim otapalom za namještanje pH smjese između 7,0-7,5.
5. Metoda pripreme argatroban monohidrata prema zahtjevu 4, pri čemu je bazično otapalo izabrano između natrijevog hidroksida, natrijevog bikarbonata i amonijaka u koncentraciji 10-30%.
6. Metoda pripreme argatroban monohidrata prema zahtjevu 1, pri čemu je kristalizacija ili rekristalizacija iz metanolno-vodenog medija postignuta podvrgavanjem smjese sljedećem temperaturnom gradijentu: zagrijavanje na 90-95°C, održavanje na refluks temperaturi 1-3 sata, hlađenje na 70-75°C tijekom najmanje jednog sata i održavanje na toj temperaturi najmanje jedan sat, hlađenje na 20°C tijekom 2-6 sati i održavanje na toj temperaturi najmanje 6 sati.
7. Metoda prema zahtjevu 1, pri čemu metanolno-vodeni medij ima koncentraciju od 10-20% alkohola i kvantitativno iznosi do 50 volumena po gramu pročišćenog argatrobana.
8. Metoda pripreme argatroban monohidrata prema zahtjevu 1 koja sadrži daljnji korak sušenja dobivenog kristaliničnog precipitata argatroban monohidrata.
9. Metoda pripreme argatroban monohidrata koja sadrži korake definirane u zahtjevima 1-8.
10. Metoda pripreme anhidričnog argatrobana koja sadrži najmanje jedan korak od: Pripreme argatroban monohidrata prema metodi definiranoj u zahtjevima 1-8; Njegova rekristalizacija, nakon otapanja u vodi, brzim hlađenjem na 10-20°C unutar ne više od 2 minute.
11. Pročišćeni argatroban karakteriziran sljedećim parametrima: Točka tališta 183-185°C; I.R. spektar (KBr) (cm-1) – 3399, 1270, 1160; Diferencijalna pretražna kalorimetrija s endotermnim pomakom na oko 160°C; XRPD: pik br. 1 kut (2θ) 6.800, relativni intenzitet (%) 100; pik br. 2 kut (2θ) 7.840, relativni intenzitet (%) 12; pik br. 3 kut (2θ) 9.800, relativni intenzitet (%) 13; pik br. 4 kut (2θ) 10.020, relativni intenzitet (%) 13; pik br. 5 kut (2θ) 10.700, relativni intenzitet (%) 6; pik br. 6 kut (2θ) 11.780, relativni intenzitet (%) 5; pik br. 7 kut (2θ) 13.080, relativni intenzitet (%) 12; pik br. 8 kut (2θ) 13.540, relativni intenzitet (%) 32; pik br. 9 kut (2θ) 14.540, relativni intenzitet (%) 21; pik br. 10 kut (2θ) 16.900, relativni intenzitet (%) 8; pik br. 11 kut (2θ) 17.540 , relativni intenzitet (%) 18; pik br. 12 kut (2θ) 18.640, relativni intenzitet (%) 14; pik br. 13 kut (2θ) 19.060, relativni intenzitet (%) 13; pik br. 14 kut (2θ) 19.620, relativni intenzitet (%) 13; pik br. 15 kut (2θ) 20.000, relativni intenzitet (%) 20; pik br. 16 kut (2θ) 21.420, relativni intenzitet (%) 16; pik br. 17 kut (2θ) 21.780, relativni intenzitet (%) 21; pik br. 18 kut (2θ) 22.660, relativni intenzitet (%) 15; pik br. 19 kut (2θ) 23.680, relativni intenzitet (%) 15; pik br. 20 kut (2θ) 24.080, relativni intenzitet (%) 16;pik br. 21 kut (2θ) 24.740, relativni intenzitet (%) 25; pik br. 22 kut (2θ) 25.340, relativni intenzitet (%) 9; pik br. 23 kut (2θ) 26.480, relativni intenzitet (%) 10; pik br. 24 kut (2θ) 27.580, relativni intenzitet (%) 10; pik br. 25 kut (2θ) 28.220, relativni intenzitet (%) 7; pik br. 26 kut (2θ) 29.120, relativni intenzitet (%) 8; pik br. 27 kut (2θ) 29.740, relativni intenzitet (%) 11; pik br. 28 kut (2θ) 31.820, relativni intenzitet (%) 9; pik br. 29 kut (2θ) 34.840, relativni intenzitet (%) 7; pik br. 30 kut (2θ) 40.580, relativni intenzitet (%) 6; Otapa se u izopropanolu.
HRP20150456TT 2008-04-07 2015-04-28 Metoda pripreme argatroban monohidrata HRP20150456T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000106A ITPD20080106A1 (it) 2008-04-07 2008-04-07 Metodo di preparazione di argatroban monoidrato
PCT/EP2009/054085 WO2009124906A2 (en) 2008-04-07 2009-04-06 Method for preparing argatroban monohydrate
EP09730279.8A EP2285799B1 (en) 2008-04-07 2009-04-06 Method for preparing argatroban monohydrate

Publications (1)

Publication Number Publication Date
HRP20150456T1 true HRP20150456T1 (hr) 2015-07-03

Family

ID=40297115

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20150456TT HRP20150456T1 (hr) 2008-04-07 2015-04-28 Metoda pripreme argatroban monohidrata

Country Status (13)

Country Link
US (1) US8378106B2 (hr)
EP (2) EP2687522A1 (hr)
JP (1) JP5696035B2 (hr)
CA (1) CA2719778C (hr)
DK (1) DK2285799T3 (hr)
ES (1) ES2537067T3 (hr)
HR (1) HRP20150456T1 (hr)
HU (1) HUE025930T2 (hr)
IT (1) ITPD20080106A1 (hr)
PL (1) PL2285799T3 (hr)
PT (1) PT2285799E (hr)
SI (1) SI2285799T1 (hr)
WO (1) WO2009124906A2 (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110545A1 (it) 2011-04-04 2012-10-05 Lundbeck Pharmaceuticals Italy S P A Metodo per la preparazione di intermedi di processo per la sintesi di argatroban monoidrato
CN102408468B (zh) * 2011-09-20 2012-11-21 海南灵康制药有限公司 一种阿加曲班化合物及其制法
CN103772486B (zh) * 2014-01-06 2016-01-20 天津大学 一种阿加曲班新晶型及其制备方法
CN105218627A (zh) * 2015-11-19 2016-01-06 天津市亨必达化学合成物有限公司 一种阿加曲班手性中间体水解物的纯化方法
CN110452285B (zh) * 2019-09-12 2021-05-25 北京悦康科创医药科技股份有限公司 一种阿加曲班单晶及其培养方法与应用
CN110981934B (zh) * 2019-11-12 2021-05-25 鲁南制药集团股份有限公司 一种阿加曲班水合物的合成方法
CN111961114A (zh) * 2020-08-03 2020-11-20 扬州中宝药业股份有限公司 一种阿加曲班中间体及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201863A (en) 1974-11-08 1980-05-06 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4210863A (en) 1977-03-28 1980-07-01 Huntron Instruments, Inc. Extendible probe for use with test instruments
US4258192A (en) 1977-12-16 1981-03-24 Mitsubishi Chemical Industries Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
JPS5533499A (en) * 1978-08-31 1980-03-08 Mitsubishi Chem Ind Ltd N2-arylsulfonyl-l-arginineamide and its pharmaceutically acceptable salt
IE48623B1 (en) 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
JPH0627535B2 (ja) 1988-07-18 1994-04-13 株式会社メント研究所 無段変速機
US5925760A (en) 1996-08-07 1999-07-20 Mitsubishi Chemical Corporation Method for preparing N2 -arylsulfonyl-L-argininamides
JPH10101649A (ja) * 1996-08-07 1998-04-21 Mitsubishi Chem Corp N2 −アリールスルホニル−l−アルギニンアミド類の製造方法
CN100427480C (zh) * 2006-11-10 2008-10-22 天津市炜杰科技有限公司 阿加曲班水合物的制备方法

Also Published As

Publication number Publication date
EP2687522A1 (en) 2014-01-22
US20110028726A1 (en) 2011-02-03
CA2719778C (en) 2016-07-26
US8378106B2 (en) 2013-02-19
WO2009124906A2 (en) 2009-10-15
WO2009124906A3 (en) 2009-12-03
DK2285799T3 (en) 2015-04-27
CA2719778A1 (en) 2009-10-15
ITPD20080106A1 (it) 2009-10-08
PL2285799T3 (pl) 2015-08-31
EP2285799A2 (en) 2011-02-23
SI2285799T1 (sl) 2015-07-31
HUE025930T2 (en) 2016-05-30
EP2285799B1 (en) 2015-02-25
ES2537067T3 (es) 2015-06-02
PT2285799E (pt) 2015-07-01
JP2011516519A (ja) 2011-05-26
JP5696035B2 (ja) 2015-04-08

Similar Documents

Publication Publication Date Title
HRP20150456T1 (hr) Metoda pripreme argatroban monohidrata
ES2320172T3 (es) Procedimiento para la produccion de 5-(4-(4-(5-ciano-3-indolil)-butil)-1-piperazinil)-benzofuran-2-carboxamida.
EP2407468B1 (en) Improved method for preparing meropenem using zinc powder
RU2387656C2 (ru) Способ получения гидробромида галантамина
CN104829590B (zh) 一种纯化曲格列汀的方法
CN103936759A (zh) (3aS,6aR)-1,3-二苄基-四氢-4H-噻吩并[3,4-d]咪唑-2,4-(1H)-二酮的简便制备方法
JP2013528581A (ja) キラルなβ−アミノカルボキサミド誘導体の製造方法
CA2556659A1 (en) Direct process for the production of the dihydrochloride of an amino acid
JP5315337B2 (ja) トポテカン塩酸塩の結晶形およびその製造方法
CN112574197B (zh) 一种化合物c的手性纯化方法
CN104876812B (zh) 制备盐酸舍曲林中间体及杂质的方法
CN106432195B (zh) 一种制备(r)-2-(2-甲基吡咯烷-2-基)-1h-苯并咪唑-4-甲酰胺的方法
CN109020933A (zh) 一种麦考酚酸的纯化方法
CN106187864A (zh) 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
CZ303364B6 (cs) Opticky aktivní soli (3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyklopenta-[d][1,3]dioxol-4-olu a zpusob jejich prípravy
KR20170102340A (ko) 포로데신의 제조 방법
JP2008527012A (ja) タダラフィルの精製法
US10207986B2 (en) Method for preparing D-arginine
SK3952004A3 (sk) Spôsob izolácie 14-hydroxykodeinonu
WO2014097221A1 (en) Process for the purification of biapenem
CZ2004967A3 (cs) Způsob čištění 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-l-piperazinyl)ethoxy]ethanolu
AU2012337206B8 (en) 7-{(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal
EP2739619B1 (en) Process for the preparation of olmesartan medoxomil
CN106866641A (zh) 一种阿法替尼的精制方法
JP4919421B2 (ja) (r)‐3‐モルフォリンカルボン酸の製造方法